Report of Foreign Issuer (6-k)
November 09 2018 - 7:06AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 or 15d-16
UNDER
THE SECURITIES EXCHANGE ACT
of 1934
For the Month of November 2018
001-37521
(Commission File Number)
INTEC PHARMA LTD.
(Translation of registrant’s name
into English)
12 Hartom Street
Har Hotzvim, Jerusalem 9777512, Israel
(+972) (2) 586-4657
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover
Form 20-F or Form 40-F.
Form 20-F
☒
Form
40-F
☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(l): _________
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): _________
EXPLANATORY
NOTE
On
November 9, 2018, Intec Pharma Ltd. issued a press release titled “Intec Pharma Reports Third Quarter 2018 Financial Results
and Corporate Update.”
A
copy of the press release is attached hereto as Exhibit 99.1. Also attached are the unaudited condensed interim financial information
and Management’s Discussion and Analysis of Financial Condition and Results of Operation (as Exhibits 99.2 and 99.3, respectively),
both of which are incorporated by reference into the Company’s registration statements on Form S-8 (Files No. 333-209700,
No. 333-212801, No. 333-222217 and No. 333-227027).
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
INTEC PHARMA LTD.
|
|
|
|
|
|
|
By:
|
/s/
Nir Sassi
|
|
|
|
Name: Nir Sassi
|
|
|
|
Title: Chief Financial Officer
|
|
|
|
Date: November 9, 2018
|
|
|
|
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Apr 2023 to Apr 2024